Chromosomal stability during ex vivo expansion of UCB CD34 + cells

Cell Proliferation

Volumn 44, Issue 6, 2011, Pages 550-557

  Ge, J ^a   Cai, H ^a   Tan, W S ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; CELL CULTURE; CELL EXPANSION; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; EX VIVO STUDY; GENETIC STABILITY; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; KARYOTYPE; UMBILICAL CORD BLOOD; CYTOLOGY; FETUS BLOOD; FLOW CYTOMETRY; GENETICS; METABOLISM;

ANTIGENS, CD34; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; KARYOTYPE;

EID: 84856459921     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00779.x     Document Type: Article

References (22)

1. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman H, Douglas G, Devergie A et al. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174-1178.
2. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio A et al. (1998) Outcomes among 562 recipients of pla-cental-blood transplants from unrelated donors. N. Engl. J. Med. 339, 1565-1577.
3. Wagner JE, Barker JN, DeFor TE, Baker K, Blazar B, Eide C et al. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100, 1611-1618.
4. Wagner JE, Rosenthal J, Sweetman R, Shu X, Davies S, Ramsay N et al. (1996) Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88, 795-802.
5. Gunetti M, Ferrero I, Rustichelli D, Berger M, Gammaitoni L, Timeus F et al. (2008) Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Exp. Hematol. 36, 235-243.
6. Serrano LM, Pfeiffer T, Olivares S, Numbenjapon T, Bennitt J, Kim D et al. (2006) Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy. Blood 107, 2643-2652.
7. Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin P, Driscoll T et al. (2003) Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101, 5061-5067.
8. Israels ED, Israels LG (2001) The cell cycle. Stem Cells 19, 88-91.
9. Bodnar AG, Ouellette M, Frolkis M, Holt S, Chiu C, Morin G et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
10. Vaziri H, Benchimol S (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279-282.
11. Rubio D, Garcia-Castro J, Martin MC, De la Fuente R, Cigudosa J, Lloyd A et al. (2005) Spontaneous human adult stem cell transformation. Cancer Res. 65, 3035-3039.
12. Corselli M, Parodi A, Mogni M, Sessarego N, Kunkl A, Dagna-Bricarelli F et al. (2008) Clinical scale ex vivo expansion of cord blood-derived outgrowth endothelial progenitor cells is associated with high incidence of karyotype aberrations. Exp. Hematol. 36, 340-349.
13. Miura M, Miura Y, Padilla-Nash HM, Molinolo A, Fu B, Patel V et al. (2006) Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095-1103.
14. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson D, Wu H et al. (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475-482.
15. Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260.
16. Helman LJ, Meltzer P (2003) Mechanisms of sarcoma development. Nat. Rev. Cancer 3, 685-694.
17. Duesberg P, Li R (2003) Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2, 202-210.
18. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C (2003) The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 3, 695-701.
19. Inomata K, Oga A, Kawauchi S, Furuya T, Sasaki K (2005) Global genomic changes induced by two-stage carcinogen exposure are precancerous alterations in non-transformed human liver epithelial THLE-3 cells. Int. J. Oncol. 27, 925-931.
20. Blackburn EH (2001) Switching and signaling at the telomere. Cell 106, 661-673.
21. Dong CK, Masutomi K, Hahn WC (2005) Telomerase: regulation, function and transformation. Crit. Rev. Oncol. Hematol. 54, 85-93.
22. Hamad NM, Banik SS, Counter CM (2002) Mutational analysis defines a minimum level of telomerase activity required for tumourigenic growth of human cells. Oncogene 21, 7121-7125.